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Polycyclic aromatic hydrocarbons (PAHs) are 
widespread environmental and occupational 
contaminants formed by the incomplete 
combustion of organic material (International 
Agency for Research on Cancer 1983). 
Epidemiological studies carried out in occu-
pational settings have shown that exposure to 
these chemicals may lead to serious diseases 
such as lung cancer. Among the carcino  genic 
PAHs, benzo[a]pyrene (B[a]P) is the best 
studied, and in several studies it has served 
as a model for the carcino  genic and muta-
genic effects of PAHs. B[a]P is found in sig-
nificant amounts in diesel exhaust, cigarette 
smoke, charcoal-broiled foods, and industrial 
waste by-products (Hattemer-Frey and Travis 
1991). Although B[a]P released into the 
environ  ment can accumulate in human tissues 
to toxic levels within a short time (Agency for 
Toxic Substances and Disease Registry 1995), 
the causal relationship between exposure to 
this agent and potential reproductive prob-
lems in humans remains uncertain.
Previous studies have shown that the testis 
is an important target organ for various drugs 
and chemicals (Blazak et al. 1985; Mattison 
et al. 1990). However, little attention has 
been given to the effect that drugs and chemi-
cals have on steroido  genesis in Leydig cells, 
even though this may directly affect sperm 
production and quality. The effect of sub-
acute exposure to inhaled B[a]P on changes 
in testosterone and luteinizing hormone (LH) 
levels and epididymal sperm has been evalu-
ated in Fisher 344 rats (Archibong et al. 2008; 
Inyang et al. 2003). However, the precise cel-
lular and biochemical mechanism(s) by which 
B[a]P affects steroido  genesis in Leydig cells 
has not yet been identified.
Leydig cells, testosterone-producing cells 
located in the interstitial compartment of mam-
malian testis, support spermato  genesis in semi-
niferous tubules (Saez 1994). In the rat testis, 
LH binds to Leydig cell receptors and initiates 
the activation of adenylate cyclase, resulting 
in an attendant increase in cAMP production. 
Steroidogenic acute regulatory protein (StAR) 
transfers cholesterol from the outer membrane 
to the inner mitochondrial membrane (Stocco 
2001), where the enzyme cytochrome P450 
side chain cleavage (P450scc) resides. P450scc 
converts cholesterol into pregnenolone, 
which is ultimately transferred to smooth 
endoplasmic reticulum, where the synthesis 
of testosterone takes place via the actions of 
3β-hydroxysteroid dehydrogenase (3β-HSD), 
17α-hydroxy/C17–20lase (P450c17; CYP17A1), 
and 17β-hydroxysteroid dehydrogenase 
(17β-HSD). 
We hypothesized that long-term exposure 
to low concentrations of B[a]P might disrupt 
testosterone production by Leydig cells via the 
alteration of steroido  genic proteins or enzymes, 
such as StAR, P450scc, and 3β-HSD. To test 
this hypothesis, we examined the expression 
of these proteins in relationship to testoster-
one production in Leydig cells and evaluated 
spermato  genesis and alteration of sperm occur-
ring in the testis and epididymis.
Materials and Methods
Materials. We purchased anti-actin, anti-LH, 
anti–β-tubulin, and B[a]P from Sigma (St. 
Louis, MO, USA); collagenase type III from 
Worthington Biochemical Corp. (Lakewood, 
NJ, USA); Moloney murine leukemia virus 
(MMLV) reverse transcriptase and Taq DNA 
polymerase from Promega (Madison, WI, 
USA); and anti-P450scc and anti-ADAM3 
(disintegrin and metallopeptidase domain 3) 
antibodies from Chemicon (Temecula, CA, 
USA). Anti-StAR antibody was purchased 
from Abcam (Cambridge, UK), and anti–
3β-HSD and anti-CYP17A1 antibodies were 
obtained from Santa Cruz Biotechnology 
(Santa Cruz, CA, USA).
Animals and B[a]P treatment. Adult 
male Sprague-Dawley rats [8 weeks of age; 
250–300 g body weight (BW)] were housed 
in a climate-controlled (21 ± 2°C) animal 
room at a constant 12/12-hr light/dark cycle, 
with free access to rat chow. All procedures 
were performed in accordance with proto-
cols approved by the Dong-A University 
Animal Care and Use Committee. Animals 
were treated humanely and with regard for 
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Ba c k g r o u n d: Benzo[a]pyrene (B[a]P), a polycyclic aromatic hydrocarbon (PAH), is a   ubiquitous 
environmental pollutant that is currently suspected of being an endocrine disruptor. The testis is 
an important target for PAHs, yet insufficient attention has been paid to their effects on steroido­
genesis in Leydig cells.
oB j e c t i v e: We hypothesized that long­term exposure to low concentrations of B[a]P might disrupt 
testosterone production in Leydig cells via an alteration of steroido  genic proteins.
re s u l t s: Oral exposure to B[a]P reduced serum and intra  testicular fluid testosterone levels in 
rats. However, we did not observe serious testicular atrophy or azoospermia, although spermato­
gonial apoptosis was significantly increased. Compared with control cells, Leydig cells primed with 
B[a]P in vivo produced less testosterone in response to human chorionic gonadotropin (hCG) 
or dibutyl cyclic adenosine monophosphate in vitro. Of note, the reduction of testosterone levels 
was accompanied by decreased expression of steroido  genic acute regulatory protein (StAR) and 
3β­hydroxysteroid dehydrogenase (3β­HSD), as well as increased levels of cytochrome P450 side 
chain cleavage (P450scc), in Leydig cells. The up­regulation of P450scc expression after exposure 
to B[a]P appears to be associated with a compensatory mechanism for producing the maximum 
amount of pregnenolone with the minimum amount of transported cholesterol by StAR; the down­
regulation of 3β­HSD may occur because B[a]P can negatively target 3β­HSD, which is required 
for testosterone production.
co n c l u s i o n s: B[a]P exposure can decrease epididymal sperm quality, possibly by disturbing 
  testosterone levels, and StAR may be a major steroido  genic protein that is targeted by B[a]P or 
other PAHs.
key w o r d s : benzo[a]pyrene, endocrine disruptor, epididymal sperm, Leydig cells, steroido­
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alleviation of suffering. The rats received 
B[a]P for 90 days by daily gavage at doses 
of 0.001, 0.01, or 0.1 mg/kg BW per day 
(n = 20–25 rats per dose). Control animals 
(n = 25) received the same weight-based vol-
ume of vehicle (0.5% DMSO). On day 90, 
the rats were sacrificed and the testes and 
epididymides were removed. The left testis 
was used to collect interstitial fluid (IF), and 
the right testis was used for subsequent Leydig 
cell isolation. For histological studies, the rats 
were anesthetized with sodium pentobarbital, 
and testes were fixed by perfusing Bouin’s 
fixative through the dorsal aorta.
Collection of IF and hormone assays. 
IF was collected according to a previously 
described method (Turner et al. 1984). We 
determined testosterone concentrations in 
serum, IF, and culture medium for duplicate 
samples using a testosterone ELISA kit (IBL, 
Hamburg, Germany) following the manufac-
turer’s instructions. The sensitivity of the assay 
was 0.083 ng/mL, and the intra- and inter-
assay coefficients of variation (CVs) were 3.3% 
and 6.7%, respectively. LH concentration in 
serum was determined for duplicate samples 
using an LH ELISA kit (LH Detect®; INRA, 
Nouzilly, France). The sensitivity of the assay 
was 0.01 ng/mL, and the intra- and inter  assay 
CVs were 4% and 8%, respectively.
Leydig cell isolation and culture. Leydig 
cells were isolated as described previously 
(Klinefelter et al. 1987), with slight modifica-
tions. The testes were decapsulated, placed 
in a dissociation buffer [M-199 medium 
with 2.2 g/L HEPES, 1.0 g/L bovine serum 
albumin (BSA), 2.2 g/L sodium bicarbon-
ate (pH 7.4), and 25 mg/L trypsin inhibitor] 
containing collagenase (0.25 mg/mL) at 34°C, 
and shaken for 30 min. Digested testes were 
passed through a 100-μm nylon mesh, and 
Leydig cells were purified by Percoll gradient 
separation. The final purity of the Leydig cells, 
determined by staining the cells for 3β-HSD 
activity, was consistently approximately 90%. 
We performed the Leydig cell culture as 
described previously (Klinefelter and Ewing 
1988), with minor modifications. Briefly, 
isolated Leydig cells were resuspended in 
M-199 medium containing 15 mM HEPES, 
0.1% BSA, 5 μg/mL gentamicin, 50 U/mL 
penicillin, and 50 μg/mL streptomycin. The 
cells (1.0 × 106) were then added to a six-well 
culture plate and cultured for 24 hr without 
serum in the absence or presence of hCG (25 
IU/mL) or dibutyl cyclic adenosine mono-
phosphate (dbcAMP; 50 μM) at 34°C in 5% 
CO2:95% air.
Immunocytochemistry and immuno  histo­
chemistry. Isolated Leydig cells were attached to 
the glass slide by cytospin centrifugation. The 
cells were fixed with 4% paraformaldehyde, 
washed with phosphate-buffered saline (PBS), 
and incubated with 0.2% Triton X-100. Then, 
the cells were incubated with the appropriate 
primary antibody in 1% BSA at room temper-
ature (RT). For secondary antibody reactions, 
the cells were incubated with an appropriate 
fluorescence-conjugated secondary antibody at 
RT. Finally, cells were mounted and observed 
under a confocal microscope (LSM510; Carl 
Zeiss, Hamburg, Germany). 
For immuno  histochemistry, deparaf-
finized and hydrated testis and pitui  tary gland 
sections were treated with 3% hydrogen per-
oxide (H2O2) for 5 min, rinsed with PBS 
for 15 min, and then immuno  stained using 
the Vectastain ABC kit (Vector Laboratories, 
Burlingame, CA, USA) following the manu-
facturer’s instructions.
Terminal deoxy­nucleotidyl transferase­
mediated digoxigenin­deoxyuridine triphos­
phate nick end labeling (TUNEL). Sections of 
testis were deparaffinized, hydrated, treated in 
3% H2O2 for 5 min, and rinsed with PBS for 
15 min. We then quantified apoptosis using 
the In Situ Cell Death Detection Kit, POD 
(peroxidase; Roche, Penzberg, Germany) 
following the manufacturer’s instructions. 
TUNEL-positive germ cells in the seminifer-
ous tubules were counted, ensuring that there 
were at least 20 tubules per middle portion of 
the testis section in each group.
Histological staining of the epididymis. 
Paraffin sections of the epididymis were depar-
affinized, stained with periodic acid Schiff’s 
(PAS) reagent (Sigma-Aldrich, St. Louis, MO, 
USA), counterstained with hematoxylin, and 
observed with a ScanScope digital slide scan-
ning system (Aperio, Vista, CA, USA). We 
meas  ured diameters of the caput and cauda 
epididymal tubules (35 tubules/section from 
five samples of each group) using ImageScope 
viewer software (Version 9.1.19.1569; Aperio).
Sperm preparation and analysis. Sperm 
obtained from the portion of the cauda 
epididymis that was stained were released into 
an equal amount of Dulbecco’s PBS (DPBS). 
For sperm number and motility count, 200 μL 
of sperm sample in DPBS was applied to a 
hemo  cytometer. Sperm counts were expressed 
as the sum of five squares on the hemo-
cytometer, and the percent motility was deter-
mined by counting both motile and immotile 
spermatozoa per area. For sperm acrosomal 
integrity analysis, sperm were stained with 
LysoTracker DND-26 (Invitrogen, Carlsbad, 
CA, USA) at RT for 30 min. For ADAM3 
immuno  cyto  chemistry, sperm were attached 
to a glass slide by cytospin centrifugation, and 
the attached sperm samples were fixed with 
methanol at RT for 5 min and immuno  stained 
with anti-ADAM3 antibody. Sperm nuclei 
and mitochondria were counter  stained with 
Hoechst 33258 and MitoTracker (Invitrogen), 
respectively.
Western blot analysis. We prepared Leydig 
cell lysates by incubating cell pellets in lysis 
buffer [30 mM NaCl, 0.5% Triton X  -100, 
50 mM Tris-HCl (pH 7.4), 1 mM Na3VO4, 
25 mM NaF, 10 mM Na4P2O7] for 30 min 
on ice. After the insoluble fractions were 
removed, the supernatants were collected, and 
protein concentration was determined with 
a bicinchoninic acid (BCA) protein assay kit 
(Pierce Biotechnology, Woburn, MA, USA). 
Aliquots of protein (~ 30 μg) were subjected 
to SDS-PAGE and transferred onto nitro-
cellulose membranes. The membranes were 
incubated for 1 hr at RT with a primary anti-
body in Tris-buffered saline containing 0.05% 
Tween-20 (TBS-T; pH 7.4) in the presence 
of 5% nonfat dry milk. After the membranes 
were washed in TBS-T, they were incubated 
with horseradish peroxidase–conjugated sec-
ondary antibody. The signals were detected 
with an enhanced chemiluminescence detec-
tion kit (Amersham Pharmacia Biotech, 
Piscataway, NJ, USA) in the LAS-3000 detec-
tor (Fujifilm, Tokyo, Japan). 
Reverse­transcription polymerase chain reac­
tion (RT­PCR). Total cellular RNA was isolated 
from isolated Leydig cells using Trizol reagent 
Figure 1. Effect of B[a]P treatment on BW (A), testis weight (B), and testosterone concentrations in serum (C) and intra  testicular fluids (D). Testosterone levels 
were measured by ELISA (C and D). Data are mean ± SD (n = 9). 
*p < 0.05 compared with control. 
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(Invitrogen). The cDNA was synthesized from 
5 μg total RNA using an oligo-dT random 
primer and MMLV RNase H– reverse tran-
scriptase. cDNA (3 μL) was subjected to PCR 
(18 cycles) for P450scc, StAR, and 3β-HSD 
in 30 μL reaction mixture [10× PCR buffer, 
2.5 mM dNTP (deoxynucleotide triphos-
phate), Taq-polymerase 5 U, and upstream 
and downstream primers; see Supplemental 
Material, Table 1 (http://dx.doi.org/10.1289/
ehp.1003391)]. The PCR products were 
resolved by 2% agarose gel electro  phoresis and 
visualized using ethidium bromide. 
Statistical analysis. Data are expressed 
as the mean ± SD of three or four separate 
experiments. Where appropriate, data were 
subjected analysis of variance followed by 
Duncan’s post hoc test. Means were consid-
ered significantly different at p < 0.05.
Results
Effect of B[a]P on body and testicular weights 
and testosterone concentrations in serum 
and intratesticular fluids. To investigate 
whether exposure to B[a]P provoked the dis-
ruption of the male reproductive endocrine 
system, we treated adult Sprague-Dawley 
rats with B[a]P (0.001, 0.01, or 0.1 mg/kg 
BW/day) for 90 days by gavage. Compared 
with DMSO treatment, none of the B[a]P 
doses significantly altered BW (Figure 1A) or 
testicular weight (Figure 1B). However, tes-
tosterone concentrations in both serum and 
intra  testicular were reduced after treatment 
with B[a]P, most remarkably in the 0.1 mg/kg 
group (Figure 1C,D). 
Occurrence of germ cell apoptosis and 
sperm changes in the epididymis after 
B[a]P treatment. The withdrawal of testos-
terone, especially intra  testicular testosterone, 
causes germ cell apoptosis and thereby deple-
tion of spermatozoa in the testis (Kim et al. 
2001). Thus, we analyzed the occurrences 
of testicular germ cell apoptosis and sperm 
changes in the epididymis. In the B[a]P-treated 
groups, the number of apoptotic germ cells 
detected by TUNEL increased (Figure 2A) 
in a dose-dependent manner (Figure 2B); in 
contrast, TUNEL-positive cells were rare in 
controls (Figure 2A). Consistent with these 
results, activated caspase-3 proteins were posi-
tively stained in the apoptotic germ cells of 
testes in the B[a]P-exposed groups but not in 
controls (Figure 2C,D). We did not detect 
either TUNEL-positive or active caspase-3–
positive staining in other testicular cell types 
(i.e., Leydig cells or Sertoli cells) in any of the 
groups. The apoptotic germ cells formed after 
exposure to B[a]P were mostly restricted to the 
spermato  gonia; other types of germ cells in the 
spermato  genic lineage appeared to be intact. 
In the epididymis, exposure to B[a]P resulted 
in a noticeable reduction in diameter of caput 
epididymal tubules [see Supplemental Material, 
Figure 1A,B (http://dx.doi.org/10.1289/
ehp.1003391)] as well as that of the cauda 
epididymal tubules (see Supplemental 
Material, Figure 1C,D). Epididymal sperm 
numbers appeared to be lower in B[a]P-treated 
groups than in controls, but the difference was 
insignificant (Figure 3A). However, sperm 
motility was significantly reduced in the 
B[a]P-exposed groups compared with controls 
(Figure 3B). Qualitatively, acrosomal integ-
rity detected by LysoTracker DND-26 stain-
ing was remarkably reduced in sperm heads 
from the cauda epididymis of rats exposed to 
B[a]P compared with controls (Figure 3C; 
see also Supplemental Material, Figure 2A). 
Furthermore, protein analysis of ADAM3, 
Figure 2. Incidence of apoptotic germ cell death after treatment with B[a]P (0, 0.001, 0.01, or 0.1 mg/kg BW/
day) for 90 days. (A) TUNEL staining of testes (original magnification, 100×) and (B) quantitation of TUNEL-
positive germ cells in seminiferous tubules. (C) Immunolocalization of active caspase-3 in testes (original 
magnification: 400×) and (D) quantitation of active caspase-3–positive germ cells in seminiferous tubules. 
In A and C, arrows indicate TUNEL-positive germ cells and active caspase-3-positive germ cells, respec-
tively; bar = 100 µm. In B and D, values shown are mean ± SD (n = 180 tubules from nine testes).
*p < 0.05 compared with control. 
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Figure 3. Alterations in sperm number, sperm motility, and qualitative markers of sperm after treatment 
with B[a]P (0, 0.001, 0.01, or 0.1 mg/kg BW/day) for 90 days. CON and B[a]P indicate 0 mg/kg BW (control) 
and 0.01 mg/kg BW groups, respectively. Change (mean ± SD) in sperm number (A) and sperm motility (B). 
(C) Changes in acrosomal integrity evaluated by LysoTracker DND-26 fluorescence staining (original mag-
nification, 1,600×). (D and E) Changes in ADAM3 proteins detected by immuno  cytochemistry (D; original 
magnification, 1,600×; bar = 5 μm) and (E) Western blotting. (F) Densitometric quantification of ADAM3 
protein content in sperm protein extracts (mean ± SD).
*p < 0.05, and **p < 0.01 compared with control. 
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a sperm surface protein associated with the 
fertilization process (Nishimura et al. 2004), 
revealed that this protein was down-regulated 
in the sperm surfaces of B[a]P-treated groups 
(Figure 3D; see also Supplemental Material, 
Figure 2B), and its content was significantly 
decreased in B[a]P-exposed groups compared 
with controls (Figure 3E,F). 
Capability for testosterone production 
is reduced in Leydig cells that are exposed 
in vivo to B[a]P. To monitor their testoster-
one production capability, we cultured Leydig 
cells isolated from the testes of controls and 
B[a]P-exposed rats in the absence or pres-
ence of hCG or dbcAMP. hCG or dbcAMP 
remarkably stimulated testosterone production 
in control Leydig cells (Figure 4). However, 
hCG- or dbcAMP-stimulated testosterone 
production was lower in cells primed with 
B[a]P in vivo; this was most evident in the 
groups treated with 0.01 and 0.1 mg/kg BW 
(Figure 4B,C). In addition, spontaneous testos-
terone production in cultures without hCG or 
dbcAMP was also reduced in the B[a]P-primed 
cells, although the differences with respect to 
controls were relatively smaller than those in 
hCG or dbcAMP-treated cultures (Figure 4A).
Changes in StAR, P450scc, and 3β­HSD 
expression in Leydig cells after in vivo expo­
sure to B[a]P. It has long been known that 
StAR, P450scc, and 3β-HSD are prerequi-
sites for testosterone production in Leydig cells 
of the mammalian testis (Zirkin and Chen 
2000). Therefore, delineating the changes of 
these proteins in Leydig cells is important 
in discovering the precise mechanism(s) by 
which B[a]P affects testosterone produc-
tion. Figures 5 and 6 show the effects of 
B[a]P exposure on the expression of steroido-
genic proteins in Leydig cells. Long-term 
exposure to B[a]P resulted in down-regulation 
of StAR and 3β-HSD expression, as shown 
by Western blotting (Figure 5A), RT-PCR 
(Figure 5C), and immuno  cytochemistry 
using isolated Leydig cells [see Supplemental 
Material, Figure 3 (http://dx.doi.org/10.1289/
ehp.1003391)]. However, P450scc expression 
was substantially up-regulated after exposure 
to B[a]P [Figure 5A,C; see also Supplemental 
Material, Figure 3). We further confirmed 
these observations by immuno  histochemistry 
of the testicular sections (Figure 6; see also 
Supplemental Material, Figure 4). A decrease 
of StAR (Figure 6C,D) and 3β-HSD 
(Figure 6J–L), in the Leydig cells was evi-
dent in the B[a]P-exposed groups. In con-
trast, immuno  reactivity for P450scc proteins 
was more intense in the B[a]P-treated groups 
(Figure 6G,H) than in controls (Figure 6E). 
Additionally, we examined the change in 
CYP17A1 expression in Leydig cells, because 
this enzyme is particularly decreased after expo-
sure to exo  biotic toxi  cants (Akingbemi et al. 
2004). Exposure to B[a]P caused a significant 
decrease in CYP17A1 expression in Leydig 
cells at both translational and transcriptional 
levels (see Supplemental Material, Figure 4). 
Chronic exposure to B[a]P does not 
directly affect LH release from the pituitary 
gland. We initiated this study on the basic 
premise that chronic exposure to B[a]P results 
in a decrease in testosterone production due 
to disturbances in the steroido  genic machin-
ery of Leydig cells. However, it is still uncer-
tain whether the testosterone reduction is due 
to decreased LH levels arising from the direct 
and negative effects of B[a]P on the neuro-
endocrine system. To assess this possibility, 
we measured LH concentrations in serum and 
monitored expression levels of LH protein 
in tissue samples from the pituitary glands. 
Exposure to B[a]P resulted in significant 
increases in serum LH levels (Figure 7A) and 
LH proteins (~ 20 kDa) in pituitary gland 
extracts (Figure 7B) and in the intensity of 
LH immuno  reactivity in the gonadotropes in 
the anterior pituitary glands (Figure 7C). 
Discussion
B[a]P is known to have xenoestrogenic action 
(Santodonato 1997) and is currently con-
sidered to be an endocrine disruptor (Hoyer 
2001). B[a]P is present in cigarette smoke at 
a concentration of 20–40 ng/cigarette (Kuller 
et al. 1986); coke oven workers are exposed 
to approximately 42 μg B[a]P/m3 (Lewtas 
et al. 1997); and indoor exposure to B[a]P 
from cooking oil fumes reaches 20 μg B[a]P/
Figure 4. Testosterone production capability of testicular Leydig cells from rats exposed to B[a]P. Leydig 
cells were isolated from testes of B[a]P-exposed rats and cultured for 24 hr in the absence (control; A) 
or presence of hCG (25 IU/mL; B) or dbcAMP (50 μM; C). Testosterone levels in media (mean ± SD) were 
measured by ELISA and represent three independent experiments performed in triplicate. 
*p < 0.05 compared with control. 
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Figure 5. Changes in StAR, P450scc, and 3β-HSD protein and gene expression in testicular Leydig cells 
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m3 (Chiang et al. 1997). Nevertheless, the 
effect of chronic exposure to B[a]P on hor-
monal dys  regu  la  tion in various mammalian 
endocrine glands has not yet been investi-
gated. Furthermore, the precise cellular and 
bio  chemi  cal mechanism(s) by which B[a]P 
disrupts the reproductive endocrine system 
should be determined. The exposure levels 
of B[a]P used in our study (0.5–50 ng/day   
for an average rat weighing 0.5 kg) are consid-
ered environ  mentally relevant, because B[a]P 
intake has been estimated to range from 20 
to 800 ng/day in humans (0.3–13.3 ng/day 
for an average man weighing 60 kg) who 
lives near hazardous waste sites contaminated 
with PAHs (Lioy et al. 1988). In the present 
study, we found that oral exposure to low 
concentrations of B[a]P reduced testoster-
one production in Leydig cells via altera  tions 
in the levels of steroido  genic proteins (espe-
cially down-regulation of StAR), which led to 
reduced sperm quality in the epididymis.
In mammalian male reproduction, testos-
terone, produced by Leydig cells in response 
to LH, plays a pivotal role in the initiation and 
maintenance of spermato  genesis by affecting 
Sertoli cell androgen receptors. Thus, an abnor-
mal reduction in serum or intratesticular fluid 
testosterone levels can cause testicular atrophy, 
which is accompanied by a decrease in the 
number of germ cells and, ultimately, azoo-
spermia (Awoniyi et al. 1989). In the present 
study, oral exposure to B[a]P resulted in reduc-
tion of serum and intra  testicular fluid testos-
terone levels. However, although both serum 
and intra  testicular testosterone levels were 
decreased, testicular atrophy or azoospermia 
did not occur; this indicates that the reduc-
tion in testosterone levels was not sufficient 
to induce massive germ cell degeneration. In 
fact, it has been shown that a lower concentra-
tion (< 20 ng/mL) of intra  testicular testoster-
one needs to be present for at least 4 weeks to 
achieve azoospermia in rat testes (Kim et al. 
2001; McLachlan et al. 1994). However, in the 
present study, the intra  testicular testosterone 
level in the group treated with the highest dose 
of B[a]P (0.1 mg/kg BW) dropped to around 
50 ng/mL. Based on the extent of apoptosis 
we observed, we cannot exclude the possibility 
that germ cell (mostly spermato  gonia) apoptosis 
might be provoked by the direct cyto  toxic effect 
of B[a]P treatment. Indeed, exposure to many 
types of chemical agents is known to induce 
spermato  gonial apoptosis with no change in 
testosterone concentration (Boekelheide and 
Hall 1991; Meistrich et al. 2003).
Although we observed no serious 
spermato  genic effects after B[a]P exposure 
in the present study, the reduced testoster-
one levels appeared to be more closely cor-
related with decreased sperm quality than 
with the occurrence of germ cell apoptosis. 
In the epididymis, testosterone is a critical 
substance because it is converted to dihydro-
testosterone by 5α-reductase (Robaire et al. 
1977). Therefore, testosterone is very impor-
tant for the regulation of epididymal epithe-
lial cell function as well as for maturation of 
spermatozoa. Our results indicate that B[a]P 
can disrupt testosterone production in Leydig 
cells, which may ultimately lead to a decrease 
in sperm quality in the epididymis via reduced 
levels of sperm motility, acrosomal integrity, 
and fertility-related proteins such as ADAM3 
(Nishimura et al. 2004).
The rate-limiting enzymatic reaction in 
steroido  genesis is catalyzed by P450scc (Kahnt 
et al. 1974). However, it has been suggested 
Figure 7. Effects of exposure to B[a]P (0, 0.001, 
0.01, and 0.1 mg/kg/BW) on LH serum levels 
and protein expression in the pituitary glands of 
B[a]P-exposed rats. (A) LH levels meas  ured in 
serum by ELISA (mean ± SD; n = 9). (B) Western blot 
analysis of protein extracts from pituitary glands. 
(C) Immunohistochemical localization of LH in the 
anterior pituitary glands. Original magnification: 
400×; bar = 20 μm.
aNonspecific band. *p < 0.05 compared with the control. 
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that the physiologically relevant rate-limiting 
step is the transfer of free cholesterol from the 
outer mitochondrial membrane to the inner 
membrane where the P450scc resides (Stocco 
and Chen 1991). Currently, this transfer is 
thought to be mediated in part by the StAR 
protein (Stocco 2001). The present study is 
the first to show that long-term exposure to 
B[a]P decreases StAR expression and increases 
P450scc expression in Leydig cells. We found 
that B[a]P-primed Leydig cells in vivo pro-
duced less testosterone in response to hCG or 
dbcAMP in vitro compared with control cells. 
Given that testosterone production decreases 
after exposure to B[a]P, it may be assumed 
that StAR is one of the major target proteins 
affected by B[a]P during testosterone synthesis. 
In fact, the decrease in StAR expression in iso-
lated Leydig cells after exposure to B[a]P was 
completely restored by supplementation with 
hCG [see Supplemental Material, Figure 5 
(http://dx.doi.org/10.1289/ehp.1003391)], 
and elevated testosterone production upon 
hCG or dbcAMP stimulation remained static 
at all concentrations of B[a]P. These results 
support evidence that StAR may be one of 
the major steroido  genic proteins involved in 
the disturbance of testosterone production in 
Leydig cells after exposure to B[a]P.
In the present study, P450scc expression 
in Leydig cells was up-regulated after expo-
sure to B[a]P (Figures 5, 6); this appears to 
be associated with a compensatory phenom-
enon related to producing the maximal amount 
of pregnenolone with a minimal amount of 
transported cholesterol by the reduced StAR 
content, but the association remains uncertain 
at present. We also found that 3β-HSD expres-
sion was decreased in Leydig cells after exposure 
to B[a]P. The HSDs are essential for steroido-
genesis in Leydig cells (Payne and Youngblood 
1995). 3β-HSD, 17α-hydroxylase, and 
17β-HSD are required for the synthesis of ste-
roids. 11β-HSD, 3α-HSD, and 5α-reductase 
are also involved in the synthesis, as well as 
metabolism, of steroids. Among these, 3β-HSD 
is considered to be a key enzyme necessary for 
the synthesis of testosterone in Leydig cells of 
rats (Haider et al. 1986). In the present study, 
the down-regulation of 3β-HSD expression 
after B[a]P exposure did not appear to be the 
result of an arbitrary cytotoxic action of B[a]P 
because P450scc expression was up-regulated 
by B[a]P. 17α-Hydroxylase (CYP17A1) in rat 
Leydig cells has been shown to be very sensi-
tive to exo  biotic toxi  cants such as bisphenol A 
(Akingbemi et al. 2004). Similarly, our results 
demon  strated that CYP17A1 expression is 
down-regulated in Leydig cells of rats exposed 
to B[a]P. This indicates that 3β-HSD and 
CYP17A1 could also be potential targets of 
B[a]P in the testicular steroido  genic   machinery.
Finally, to confirm whether decreased tes-
tosterone concentration is related to the direct 
inhibition of neuro  endocrine function by 
B[a]P, we monitored the changes in the serum 
LH level and expression of LH proteins in the 
pituitary glands. Unexpectedly, chronic B[a]P 
exposure significantly increased both serum 
LH concentration and LH protein expression 
in the pituitary glands. Similarly, an eleva-
tion in serum LH levels was recently observed 
in F-344 male rats after B[a]P inhalation 
(Archibong et al. 2008). Such up-  regulation 
of LH levels is believed to be associated with 
the reduced negative feedback regulation trig-
gered by decreased testosterone levels in blood 
circulation. Therefore, the possibility that tes-
tosterone production was reduced via direct 
inhibition of the neuro  endocrine system 
after B[a]P exposure can be disregarded. We 
believe that it is not likely that the pituitary is 
a direct target of B[a]P action.
Conclusion
Our data indicate that long-term exposure to 
B[a]P results in a significant reduction in both 
serum and intra  testicular testosterone levels. 
The decrease was insufficient to cause testicu-
lar atrophy with massive germ cell apoptosis 
but appeared to be associated with a reduc-
tion in sperm quality in the epididymis. The 
down-regulation of StAR expression might 
be an important factor through which testos-
terone production is interrupted after B[a]P 
exposure. Our study suggests that B[a]P expo-
sure can decrease epididymal sperm quality by 
reducing the testosterone level and that StAR 
could be an important steroido  genic protein 
that is targeted by B[a]P or other PAHs. 
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